M M Kahl-McDonagh
Overview
Explore the profile of M M Kahl-McDonagh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
141
Followers
0
Related Specialties
Related Specialties
Co-Authors
Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Arenas-Gamboa A, Rice-Ficht A, Fan Y, Kahl-McDonagh M, Ficht T
Clin Vaccine Immunol
. 2011 Dec;
19(2):249-60.
PMID: 22169089
The global distribution of brucellosis and high incidence in certain areas of the world warrant the development of a safer and efficacious vaccine. For the past 10 years, we have...
2.
Arenas-Gamboa A, Rice-Ficht A, Kahl-McDonagh M, Ficht T
Infect Immun
. 2011 Jun;
79(9):3653-8.
PMID: 21708998
Brucellosis is a zoonosis of nearly worldwide distribution. Vaccination against this pathogen is an important control strategy to prevent the disease. Currently licensed vaccine strains used in animals are unacceptable...
3.
Arenas-Gamboa A, Ficht T, Kahl-McDonagh M, Gomez G, Rice-Ficht A
Infect Immun
. 2008 Dec;
77(2):877-84.
PMID: 19047401
Brucellosis is an important zoonotic disease of nearly worldwide distribution. Despite the availability of live vaccine strains for bovine (S19, RB51) and small ruminants (Rev-1), these vaccines have several drawbacks,...
4.
Kahl-McDonagh M, Arenas-Gamboa A, Ficht T
Infect Immun
. 2007 Aug;
75(10):4923-32.
PMID: 17664263
Brucellosis is a zoonotic disease with a worldwide distribution that can be transmitted via intentional or accidental aerosol exposure. In order to engineer superior vaccine strains against Brucella species for...
5.
Kahl-McDonagh M, Ficht T
Infect Immun
. 2006 Jun;
74(7):4048-57.
PMID: 16790778
Research for novel Brucella vaccines has focused upon the development of live vaccine strains, which have proven more efficacious than killed or subunit vaccines. In an effort to develop improved...